FAF
GILD icon

Första AP-fonden’s Gilead Sciences GILD Stock Holding History

Första AP-fonden’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-262,000
Closed -$32.2M – 222
2025
Q4 		$32.2M Sell
262,000
-6,500
-2% -$790K 0.19% 92
2025
Q3 		$29.8M Sell
268,500
-27,800
-9% -$3.16M 0.18% 103
2025
Q2 		$32.9M Sell
296,300
-40,600
-12% -$4.32M 0.22% 77
2025
Q1 		$37.7M Sell
336,900
-55,200
-14% -$5.7M 0.29% 64
2024
Q4 		$36.2M Sell
392,100
-5,300
-1% -$477K 0.26% 69
2024
Q3 		$33.3M Buy
397,400
+12,900
+3% +$984K 0.26% 73
2024
Q2 		$26.4M Buy
384,500
+19,600
+5% +$1.31M 0.23% 77
2024
Q1 		$26.7M Buy
364,900
+96,000
+36% +$7.38M 0.23% 84
2023
Q4 		$21.8M Sell
268,900
-19,600
-7% -$1.53M 0.22% 88
2023
Q3 		$21.6M Buy
288,500
+200
+0.1% +$15.4K 0.24% 76
2023
Q2 		$22.2M Sell
288,300
-48,400
-14% -$3.86M 0.24% 80
2023
Q1 		$27.9M Sell
336,700
-70,100
-17% -$5.81M 0.33% 61
2022
Q4 		$34.9M Buy
406,800
+101,000
+33% +$8M 0.39% 51
2022
Q3 		$18.9M Sell
305,800
-63,800
-17% -$4.02M 0.23% 98
2022
Q2 		$22.8M Buy
369,600
+31,500
+9% +$1.95M 0.3% 68
2022
Q1 		$20.1M Buy
338,100
+24,400
+8% +$1.56M 0.23% 84
2021
Q4 		$22.8M Buy
313,700
+21,000
+7% +$1.45M 0.23% 85
2021
Q3 		$20.4M Buy
292,700
+2,300
+0.8% +$162K 0.23% 85
2021
Q2 		$20M Buy
290,400
+18,800
+7% +$1.26M 0.24% 82
2021
Q1 		$17.6M Buy
271,600
+8,600
+3% +$555K 0.25% 83
2020
Q4 		$15.3M Buy
263,000
+48,800
+23% +$2.94M 0.23% 89
2020
Q3 		$13.5M Buy
214,200
+41,000
+24% +$2.84M 0.28% 73
2020
Q2 		$13.3M Buy
173,200
+29,600
+21% +$2.27M 0.35% 61
2020
Q1 		$10.7M Buy
+143,600
New +$9.92M 0.39% 57

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Första AP-fonden's GILD Position: Q1 2026 in Review

Första AP-fonden sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 262,000 shares — an estimated $32.2M sold.

Första AP-fonden first reported a position in GILD in Q1 2020 and held it in 24 quarters. The position peaked at $37.7M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Första AP-fonden reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Första AP-fonden sold 262,000 Gilead Sciences shares in Q1 2026, an estimated $32.2M.
  • Första AP-fonden first reported a position in Gilead Sciences in Q1 2020 and held it in 24 quarters.
  • Första AP-fonden's Gilead Sciences position peaked at $37.7M in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Första AP-fonden's 13F filing for Q1 2026.